Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

SCLC × Drug Therapy × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 137 Breast Neoplasms 90 Colorectal Neoplasms 67 Neoplasms 56 Lung Neoplasms 50 Stomach Neoplasms 47 Neoplasm Metastasis 45 Pancreatic Neoplasms 43 Rectal Neoplasms 39 Ovarian Neoplasms 39 Esophageal Squamous Cell Carcinoma 36 Esophageal Neoplasms 31 Squamous Cell Carcinoma of Head and Neck 28 Head and Neck Neoplasms 28 Leukemia, Myeloid, Acute 26 Triple Negative Breast Neoplasms 21 Recurrence 21 Precursor Cell Lymphoblastic Leukemia-Lymphoma 20 Nasopharyngeal Carcinoma 20 Colonic Neoplasms 20 Small Cell Lung Carcinoma 19 Lymphoma 17 Glioblastoma 17 Fallopian Tube Neoplasms 17 Uterine Cervical Neoplasms 16 Prostatic Neoplasms 16 Lymphoma, Non-Hodgkin 16 Sarcoma 15 Leukemia 14 Carcinoma, Squamous Cell 14

Interventions

Paclitaxel 2 Etoposide 2 Carboplatin 2 sintilimab 1 pembrolizumab 1 olaparib 1 ceralasertib 1 atezolizumab 1 apatinib 1 Topotecan 1 Platinum 1 Immune Checkpoint Inhibitors 1 Drug Therapy 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07145333 2025-09-08

Drug-SNP

Medicine Invention Design, Inc

Phase 2/3 Active not recruiting

SCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡